Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?

Weschules, Douglas J

Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting? [electronic resource] - The American journal of hospice & palliative care - 135-49 p. digital

Publication Type: Comparative Study; Journal Article

1049-9091

10.1177/104990910602300211 doi


Algorithms
Anti-Anxiety Agents--administration & dosage
Antiemetics--administration & dosage
Cohort Studies
Dose-Response Relationship, Drug
Evidence-Based Medicine
Female
Fentanyl--economics
Hospice Care--economics
Humans
Hypnotics and Sedatives--administration & dosage
Male
Narcotics--economics
Nausea--drug therapy
Ondansetron--economics
Pain--drug therapy
Pharmaceutical Services--organization & administration
Prochlorperazine--economics
Pyridines--economics
Retrospective Studies
Sleep Initiation and Maintenance Disorders--drug therapy
Southeastern United States
Temazepam--economics
Zolpidem